Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-000958
Filing Date
2017-06-09
Accepted
2017-06-09 16:44:14
Documents
1
Period of Report
2017-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06092017_010601.html 4  
1 form4-06092017_010601.xml 4 10524
  Complete submission text file 0001415889-17-000958.txt   11972
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JDJ FAMILY OFFICE SERVICES P.O. BOX 962049 BOSTON MA 02196
Business Address
Ross Edmund Burke Jr. (Reporting) CIK: 0001682557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 17903488